Newly Diagnosed AML With FLT3 Activating Mutations

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11832Crenolanib2Completed1
DB00987Cytarabine2Completed1
DB00694Daunorubicin2Completed1
DB01177Idarubicin2Completed1